Sara Lally

Ophthalmology

840 Walnut St Ste 1440
Philadelphia, PA 19107

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 127 publications

Plaque Radiotherapy for Posterior Uveal Melanoma (PUM) in 4000 Eyes in the Pre-Anti-VEGF Era: Impact of Radiation Dose to the Optic Disc and Foveola on ≥15-Letter Visual Acuity Loss.

Plaque Radiotherapy for Posterior Uveal Melanoma (PUM) in 4000 Eyes in the Pre-Anti-VEGF Era: Impact of Radiation Dose to the Optic Disc and Foveola on ≥15-Letter Visual Acuity Loss.

Journal: Retina (Philadelphia, Pa.)

Published: August 17, 2026

Choroidal Melanoma and Facial Rhabdomyosarcoma in a Young Patient With Li Fraumeni Syndrome.

Choroidal Melanoma and Facial Rhabdomyosarcoma in a Young Patient With Li Fraumeni Syndrome.

Journal: Journal of pediatric ophthalmology and strabismus

Published: August 03, 2026

RETINAL PIGMENT EPITHELIAL TUMORS IN 948 EYES OF 926 PATIENTS.

RETINAL PIGMENT EPITHELIAL TUMORS IN 948 EYES OF 926 PATIENTS.

Journal: Retina (Philadelphia, Pa.)

Published: June 17, 2026

PLAQUE RADIOTHERAPY FOR POSTERIOR UVEAL MELANOMA IN 4,000 EYES: Risk Factors for ≥15-Letter Visual Acuity Loss in the Pre-Anti-VEGF Era.

PLAQUE RADIOTHERAPY FOR POSTERIOR UVEAL MELANOMA IN 4,000 EYES: Risk Factors for ≥15-Letter Visual Acuity Loss in the Pre-Anti-VEGF Era.

Journal: Retina (Philadelphia, Pa.)

Published: May 19, 2026

Buccal mucosal graft after posterior lamellar resection for eyelid sebaceous carcinoma.

Buccal mucosal graft after posterior lamellar resection for eyelid sebaceous carcinoma.

Journal: Orbit (Amsterdam, Netherlands)

Published: April 21, 2026

PLAQUE RADIOTHERAPY FOR POSTERIOR UVEAL MELANOMA IN 4000 EYES: Analysis of ≥15-Letter Visual Acuity Loss in the Pre-anti-VEGF Era.

PLAQUE RADIOTHERAPY FOR POSTERIOR UVEAL MELANOMA IN 4000 EYES: Analysis of ≥15-Letter Visual Acuity Loss in the Pre-anti-VEGF Era.

Journal: Retina (Philadelphia, Pa.)

Published: April 06, 2026

Imiquimod for Skin Tumors and Now for Conjunctival Tumors?

Imiquimod for Skin Tumors and Now for Conjunctival Tumors?

Journal: JAMA ophthalmology

Published: November 26, 2025

LACK OF COMPLICATIONS OF HIGH-DOSE INTRAVITREAL TOPOTECAN FOR RECURRENT RETINOBLASTOMA IN 81 CONSECUTIVE INJECTIONS.

LACK OF COMPLICATIONS OF HIGH-DOSE INTRAVITREAL TOPOTECAN FOR RECURRENT RETINOBLASTOMA IN 81 CONSECUTIVE INJECTIONS.

Journal: Retina (Philadelphia, Pa.)

Published: September 15, 2025

Enucleation of an Eye With Potential High-Risk Retinoblastoma Is Currently Important for Patient Survival.

Enucleation of an Eye With Potential High-Risk Retinoblastoma Is Currently Important for Patient Survival.

Journal: Retina (Philadelphia, Pa.)

Published: September 15, 2025

Tumor Location of Uveal Melanoma and Impact on Metastasis-Free Survival in 1001 Cases.

Tumor Location of Uveal Melanoma and Impact on Metastasis-Free Survival in 1001 Cases.

Journal: Seminars in ophthalmology

Published: May 19, 2025

Artificial Intelligence in Ocular Oncology: Differentiating Choroidal Melanocytic Lesions.

Artificial Intelligence in Ocular Oncology: Differentiating Choroidal Melanocytic Lesions.

Journal: Ophthalmology science

Published: April 06, 2025

Metastasis-free survival outcomes of uveal melanoma based on The Cancer Genome Atlas classification in 1585 cases.

Metastasis-free survival outcomes of uveal melanoma based on The Cancer Genome Atlas classification in 1585 cases.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: March 30, 2025

Showing 1-12 of 127

Last Updated: 09/26/2026